Quality Assurance Associate Director
03.12.2019,
Genocea,
Management / Leadership | Change Management | Management | Training
Genocea finds targets of T cell responses to discover and develop life-changing medicines.
We’ve created a pipeline of novel vaccine and immunotherapy programs that stimulate the T cell arm of the immune system, which is increasingly recognized as critical to generating protective immune responses against a wide array of diseases.
Genocea's pipeline of novel T cell vaccines includes GEN-003 for HSV-2 therapy and GEN-004, a protein vaccine directed at pneumococcus, both currently in Phase II clinical trials.
